Search - tctmd.com

Displaying 21 - 40 of 42

Sort: Relevancy | Date

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Todd Neale

November 16, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Michael O'Riordan

January 03, 2019

News Conference News AHA 2018

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

Shelley Wood

November 11, 2018

News Conference News TCT 2018

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Shelley Wood

September 26, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Daily News

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

Michael O'Riordan

April 07, 2017

News Daily News

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

L.A. McKeown

August 11, 2016

News Daily News

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

L.A. McKeown

August 11, 2016

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

News Daily News

Subestudio del Ensayo STREAM: El Fracaso de los Agentes Líticos Equivale a Peores Resultados en Pacientes STEMI sometidos a Terapia Fármacoinvasiva

July 17, 2014

News Daily News

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

July 17, 2014

News Daily News

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Yael L. Maxwell

April 10, 2014

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

Presentation TCT 2013

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Presenter: Atsushi Hirohata, Eiki Hirose, Yuhei Kobayashi, Minako Ohara, Tohru Ohe, Fumihiko Sano, Hiroya Takafuji, Hiroyuki Takinami, Keizo Yamamoto, Ryo Yoshioka

January 31, 2013

News Daily News

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

June 05, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

Advertisement

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

T-Time: Alteplase Infusion No Help for Failed Reperfusion in STEMI PCI

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Intracoronary Shot of Morphine Fails to Limit Myocardial Infarct Size

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

Subestudio del Ensayo STREAM: El Fracaso de los Agentes Líticos Equivale a Peores Resultados en Pacientes STEMI sometidos a Terapia Fármacoinvasiva

STREAM Substudy: Lytic Failure Means Worse Outcomes for Pharmacoinvasively Treated STEMI Patients

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Un Meta Análisis Favorece el Abciximab Intracoronario frente al Abciximab Intravenoso en PCI Primarias

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content